Activity

Total Records: 187

Added to List -

2 days ago

Courtney M. Numerof & Associates

Added to List -

3 days ago

Anuj S. Tata Consultancy Services

Added to List -

3 days ago

Chris L. ProPharma

Added to List -

3 days ago

Added to List -

3 days ago

Chris L. Innomar Strategies Inc.

Added to List -

3 days ago

Chris L. Accenture

Added to List -

7 days ago

Added to List -

7 days ago

Keith P. Docxonomy

Added Case Study -

8 days ago

Keith P. Court Square Group, Inc.

Rapid Application Integration and 21 CFR Part 11 Compliant Hosting

Court Square Group, Inc. -

SUMMARY

In order to meet their first FDA submission deadline a spin-off division of a large life science company needed to implement Electronic Document Management Systems (EDMS), electronic Common Technical Document (eCTD)solutions to manage their documents, clinical trial information, and FDA submissions. The division had a corporate directive to file their initial NDA (New Drug Application) with the FDA in less than a year. Due to already overstretched resources, the corporate IT department would not be able to initiate an evaluation or begin the implementation of EDMS and eCTD solutions for at least one year.

Court Square Group (CSG) implemented and hosted multiple applications within CSG’s Audit Ready Compliant Cloud™(ARCC) environment and provided a fully functioning submission environment in less than three months. Court Square Group’s solution enabled the client to implement, train and submit the necessary documentation to the FDA for their first approval even earlier than the anticipated deadline.

THE CLIENT

The client is a new pharmaceutical start-up division of a large medical device manufacturer that was tasked with producing the first pharmaceutical products for the company. The client had a drug candidate that they intended to bring to market within the year.

Added Case Study -

8 days ago

Keith P. Court Square Group, Inc.

Case Study: The “Easy” Button for eTMF Classification Using AI to Streamline Classification of Clinical Trial Documents

Court Square Group, Inc. -

SUMMARY

A growing CRO recognized that the amount of time spent to ingest documents from multiple clinical sites over multiple trials significantly increased costs and project delays. As the number of trials expanded, the increase in costs and delays became even more troubling. The problem was compounded by a dwindling number of CRAs who possessed knowledge to classify these documents due to workforce challenges. The CRO set out to find a solution to more effectively utilize the people within the company.

ABOUT THE CLIENT

A growing CRO recognized that the amount of time spent to ingest documents from multiple clinical sites over multiple trials significantly increased costs and project delays. As the number of trials expanded, the increase in costs and delays became even more troubling. The problem was compounded by a dwindling number of CRAs who possessed knowledge to classify these documents due to workforce challenges. The CRO set out to find a solution to more effectively utilize the people within the company.

THE CHALLENGES

The first challenge was to ensure that the personnel reviewing the documents from the clinical sites were able to process those documents. Often, multiple documents were combined, scanned, saved in a single PDF and emailed to the CRAs. Extracting, separating, and determining what to do with each document was a very manual effort. CRAs needed to manually break up large files into several individual documents. After the documents were separated, CRAs needed to apply a standard naming convention.

Often clinical sites provided files with non-conforming file names. Once renamed, each document was filed into the appropriate location in the DIA eTMF file/folder structure. This labor-intensive process required knowledge of the overall eTMF structure and for the CRAs to read each document and determine the appropriate folder to store the document based on the content within.

THE SOLUTION



Added to List -

20 days ago

Added to List -

20 days ago

Michael G. Omnicia, Inc.

Added to List -

24 days ago

Joseph D. Biofourmis

Added to List -

24 days ago

Joseph D. Biofourmis

Added Webinar Recording -

25 days ago

Series topic: Vigilance Medical Device Guidance Part 2: “Post-Marketing Safety Surveillance, EU & USA"

Qinecsa Solutions -

Join us for Part 2 of our webinar series on post-marketing safety surveillance, where we dive deeper into the intricate world of medical devices and drug-device combination products.

Building upon the foundation set in Part 1, this session explores the reporting essentials and obligations associated with the post-marketing safety surveillance of these products in both the EU and USA markets. Industry expert Veronika Valdova will guide you through current trends and challenges in the industry, offering valuable insights into best practices and regulatory expectations. Attendees will gain a comprehensive understanding of how to navigate the complexities of safety surveillance and ensure compliance with international standards.

Agenda:

  • Introduction Drug-Device and Combination Products.
  • Types of DDCs in Europe and the U.S.
  • Reporting Essentials and Obligations
  • Essential Procedures to Cover
  • Comparison of Reporting Requirements in the EU vs the U.S.
  • Current Trends and/or Challenges
  • Best Practices
  • Key Takeaways
  • Q & A Session

For any questions about this webinar, or if you would like to request the recording, please write to: contact@qinecsa.com. Enjoy! 

Added to List -

49 days ago

Added to List -

50 days ago

Michael C. Uppsala Monitoring Centre

Added to List -

50 days ago

Michael C. MedDRA MSSO

Added to List -

50 days ago

Michael C. ArisGlobal

Added to List -

50 days ago

Michael C. ORACLE Health Sciences

Added to List -

50 days ago

Added to List -

50 days ago

Added to List -

50 days ago

Christopher P. Numerof & Associates

Added to List -

52 days ago

Added to List -

78 days ago

Greg R. Kivo, Inc.

Added to List -

78 days ago

Greg R. DocuSign

Added to List -

78 days ago

Heej K. Schlafender Hase

Added to List -

87 days ago

Carmin W. Numerof & Associates

Added Webinar Recording -

87 days ago

Florence D. Qinecsa Solutions

Series topic: Vigilance Medical Device Guidance Part 1- topic: “Vigilance Medical Device Regulations (EU) 2017/745

Qinecsa Solutions -


Join our insightful webinar exploring the latest developments in the EU medical device vigilance landscape, with industry-renowned specialist Veronika Valdova. Learn how to seamlessly integrate medical devices into your pharma portfolio, gain practical strategies for navigating regulations, and establish robust management processes.

Key topics include: 
• Introduction to Medical Device Regulatory Requirements
• Addressing Practical Challenges
• Key Takeaways
• Q&A Session

🎯 This webinar is ideal for: 
• MedTech company leaders in acquisition by pharma
• Pharma company leaders expanding their portfolio to include device products.

For any questions about this webinar, or if you would like to request the recording, please write to: contact@qinecsa.com. Enjoy! 

Added to List -

88 days ago

Alexa S. Numerof & Associates

Added to List -

99 days ago

Alexa S. Numerof & Associates

Added to List -

101 days ago

Beat W. Dot Compliance

Added to List -

108 days ago

Ancy J. FTI Consulting

Added to List -

113 days ago

Tong (Jenny) L. Schlafender Hase

Added to List -

121 days ago

Added to List -

121 days ago

Michael E. Cytel Inc.

Added to List -

121 days ago

Added to List -

124 days ago

Cary S. Gens & Associates, Inc.

Added to List -

124 days ago

Cary S. Cencora

Added to List -

124 days ago

Cary S. Phlexglobal - now Cencora PharmaLex

Added to List -

124 days ago

Cary S. Barrington James

Added to List -

124 days ago

Cary S. Open Text Inc

Added to List -

124 days ago

Added to List -

124 days ago

Cary S. LORENZ Life Sciences Group

Added to List -

126 days ago

Andy S. ProTrials Research, Inc.

Added to List -

126 days ago

Andy S. Mareana Inc.

Added to List -

126 days ago

Andy S. Kivo, Inc.

Added to List -

126 days ago

Andy S. Kivo, Inc.

Added to List -

128 days ago

Shy S. Drug Information Association

Added to List -

128 days ago

Shy S. Drug Information Association